Gujarat Kidney IPO
Gujarat Kidney & Super Speciality
Gujarat Kidney IPO IPO, a Mainboard IPO opens for subscription soon. The tentative listing date on the exchange (NSE,BSE) is December 30, 2025.
Stay tuned for more on Gujarat Kidney IPO including business overview, financial performance, live subscription by category, allotment links, daily grey market premium (GMP), and listing performance. This information is for education only—GMP is indicative, not advice.
Gujarat Kidney IPO MAINBOARD IPO Important Dates
Get important updates regarding Gujarat Kidney IPO MAINBOARD IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
IPO Timeline & Key Dates
* Tentative; subject to confirmation.
Price Band & Investment Details
| Listing At | NSE,BSE |
Gujarat Kidney IPO Grey Market Premium (GMP) - Current & Historical Rates
Last updated: 17 hours ago
Gujarat Kidney IPO Grey Market Premium (GMP) History - Track Record & Historical Data
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 16 Dec 2025 Latest | — | ₹0 | — | ₹0 | — | 12:00 PM |
| 15 Dec 2025 | — | ₹0 | — | ₹0 | — | 12:00 PM |
Subscription (Latest Snapshot)
View Detailed SubscriptionNo snapshot available yet.
Registrar
- Registrar
- MUFG Intime India Pvt.Ltd
- Registrar Phone
- +91-22-4918 6270
- Registrar Email
- gujaratkidney.ipo@linkintime.co.in
- Registrar Address
- C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai - 400 083, India
Promoter Holding
Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda are the company promoters.
Company Overview
Incorporated in December 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a regional multispeciality healthcare provider focused on secondary and tertiary care in central Gujarat. It operates 6 hospitals and 3 in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with a total bed capacity of 400 (operational: 250). Services span general medicine, surgery, orthopaedics, urology, cardiology, nephrology, neurology, and more, supported by in-house diagnostics.
Growth: Revenue surged from ₹0.79 Cr in FY22 to ₹4.77 Cr in FY24 and ₹18.67 Cr in H1 FY25, driven by strategic acquisitions (e.g., Raj Palmland Hospital) and expansion plans using IPO proceeds for new facilities and equipment.
Key Strengths: Strong regional presence in underserved markets, high operational efficiency (EBITDA margin ~41-50%), experienced team (322 employees, including 53 consultants and 138 nurses), low debt (D/E ratio 0.18), and focus on affordable, quality care.
- Founded In
- 2019
- Managing Director
- Dr. Pragnesh Yashwantsinh Bharpoda
- Headquarters
- Plot No. 1, City Survey No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara - 390020, Gujarat, India
- Industry
- Healthcare
Financials
| Year | Revenue (₹ Cr) | Profit (₹ Cr) | Net Worth (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| 2025 | 40.4 | — | 25.71 | 55.34 |
| 2024 | 5.48 | — | 10.8 | 20.53 |
| 2023 | 0 | -0.01 | 0.37 | 3.87 |
You may also like
